ENDRA Life Sciences Ownership 2024 | Who Owns ENDRA Life Sciences Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

0.01%

Insider Ownership

0.32%

Retail Ownership

99.67%

Institutional Holders

1.00

ENDRA Life Sciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WORTH ASSET MANAGEMENT, LLC	-	-	-	-670	-100.00%	-	Sep 30, 2023

ENDRA Life Sciences's largest institutional shareholder is WORTH ASSET MANAGEMENT, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WORTH ASSET MANAGEMENT, LLC	-	-	-	-670	-100.00%	-	Sep 30, 2023

The largest ENDRA Life Sciences shareholder by % of total assets is WORTH ASSET MANAGEMENT, LLC. The company owns 0.00 shares of ENDRA Life Sciences (NDRA), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WORTH ASSET MANAGEMENT, LLC	-	-	-	-670	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, ENDRA Life Sciences's largest institutional buyer is WORTH ASSET MANAGEMENT, LLC. The company purchased -0.67K stocks of NDRA, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WORTH ASSET MANAGEMENT, LLC	-	-	-	-670	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, ENDRA Life Sciences's biggest institutional seller is WORTH ASSET MANAGEMENT, LLC. The company sold -0.67K shares of NDRA, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WORTH ASSET MANAGEMENT, LLC	-	-	-	-670	-100.00%	-	Sep 30, 2023

ENDRA Life Sciences's largest sold out institutional shareholder by shares sold is WORTH ASSET MANAGEMENT, LLC, sold -0.67K shares, valued at -, as of undefined.

ENDRA Life Sciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	980,583	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	321,532	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	36,765	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	17,869	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	52,843	4,583	9.50%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	39,812	-39,812	-50.00%	Mar 31, 2024
Dimensional ETF Trust	0.00%	15,432	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	5,597	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	8,073	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	93,529	-	-	Mar 31, 2024

ENDRA Life Sciences's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 980.58K shares, compromising 0.00% of its total assets.

ENDRA Life Sciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	1	-
31 Mar, 23	1	-
31 Dec, 22	1	-93.33%
30 Sep, 22	15	-11.76%
30 Jun, 22	17	-5.56%
31 Mar, 22	18	-5.26%
31 Dec, 21	19	5.56%
30 Sep, 21	18	-18.18%
30 Jun, 21	22	4.76%
31 Mar, 21	21	31.25%
31 Dec, 20	16	23.08%
30 Sep, 20	13	-7.14%
30 Jun, 20	14	27.27%
31 Mar, 20	11	-
31 Dec, 19	11	-8.33%
30 Sep, 19	12	20.00%
30 Jun, 19	10	-28.57%
31 Mar, 19	14	7.69%
31 Dec, 18	13	44.44%
30 Sep, 18	9	125.00%
30 Jun, 18	4	-20.00%
31 Mar, 18	5	150.00%
31 Dec, 17	2	100.00%
30 Sep, 17	1	-
30 Jun, 17	1	-

As of 30 Jun 23, 1 institutions are holding ENDRA Life Sciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	670	148.15%
31 Mar, 23	270	-
31 Dec, 22	270	-99.99%
30 Sep, 22	3,546,597	-18.48%
30 Jun, 22	4,350,698	10.22%
31 Mar, 22	3,947,409	-10.76%
31 Dec, 21	4,423,345	26.33%
30 Sep, 21	3,501,341	-1.52%
30 Jun, 21	3,555,221	11.19%
31 Mar, 21	3,197,296	21.51%
31 Dec, 20	2,631,249	180.98%
30 Sep, 20	936,463	27.80%
30 Jun, 20	732,752	-35.71%
31 Mar, 20	1,139,805	24.89%
31 Dec, 19	912,632	-11.43%
30 Sep, 19	1,030,406	-5.52%
30 Jun, 19	1,090,561	-4.19%
31 Mar, 19	1,138,313	-8.15%
31 Dec, 18	1,239,316	311.25%
30 Sep, 18	301,350	137.59%
30 Jun, 18	126,836	73.15%
31 Mar, 18	73,254	190.34%
31 Dec, 17	25,230	567.46%
30 Sep, 17	3,780	80.00%
30 Jun, 17	2,100	-

ENDRA Life Sciences (NDRA) has 670.00 shares outstanding as of 30 Jun 23, up 148.15% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	0.01%	15429.41%
31 Mar, 23	0.01%	11764.71%
31 Dec, 22	0.01%	0.00%
30 Sep, 22	112.28%	0.56%
30 Jun, 22	141.16%	0.42%
31 Mar, 22	183.37%	0.39%
31 Dec, 21	216.18%	0.77%
30 Sep, 21	167.08%	0.57%
30 Jun, 21	170.61%	0.60%
31 Mar, 21	169.29%	0.23%
31 Dec, 20	274.20%	4.46%
30 Sep, 20	78.40%	0.79%
30 Jun, 20	99.45%	0.25%
31 Mar, 20	198.07%	0.79%
31 Dec, 19	158.60%	0.21%
30 Sep, 19	277.41%	0.32%
30 Jun, 19	293.85%	0.31%
31 Mar, 19	306.71%	0.10%
31 Dec, 18	550.21%	2.34%
30 Sep, 18	153.44%	3.67%
30 Jun, 18	64.66%	4.64%
31 Mar, 18	37.35%	22.39%
31 Dec, 17	12.92%	344.94%
30 Sep, 17	1.94%	65.14%
30 Jun, 17	1.72%	-

As of 30 Jun 23, ENDRA Life Sciences is held by 0.01% institutional shareholders, representing a 15429.41% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	1	-
31 Mar, 23	-	-
31 Dec, 22	-	-100.00%
30 Sep, 22	4	-50.00%
30 Jun, 22	8	14.29%
31 Mar, 22	7	-12.50%
31 Dec, 21	8	60.00%
30 Sep, 21	5	-61.54%
30 Jun, 21	13	-27.78%
31 Mar, 21	18	63.64%
31 Dec, 20	11	22.22%
30 Sep, 20	9	28.57%
30 Jun, 20	7	40.00%
31 Mar, 20	5	25.00%
31 Dec, 19	4	-
30 Sep, 19	4	-
30 Jun, 19	4	-60.00%
31 Mar, 19	10	-
31 Dec, 18	10	42.86%
30 Sep, 18	7	250.00%
30 Jun, 18	2	-50.00%
31 Mar, 18	4	100.00%
31 Dec, 17	2	100.00%
30 Sep, 17	1	-
30 Jun, 17	1	-

1 institutional shareholders have increased their position in NDRA stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	-	-
31 Mar, 23	-	-100.00%
31 Dec, 22	1	-66.67%
30 Sep, 22	3	50.00%
30 Jun, 22	2	-33.33%
31 Mar, 22	3	-
31 Dec, 21	3	-40.00%
30 Sep, 21	5	400.00%
30 Jun, 21	1	-
31 Mar, 21	1	-50.00%
31 Dec, 20	2	100.00%
30 Sep, 20	1	-50.00%
30 Jun, 20	2	-
31 Mar, 20	2	-
31 Dec, 19	2	-33.33%
30 Sep, 19	3	200.00%
30 Jun, 19	1	-
31 Mar, 19	1	-
31 Dec, 18	1	-
30 Sep, 18	-	-
30 Jun, 18	-	-
31 Mar, 18	-	-
31 Dec, 17	-	-
30 Sep, 17	-	-
30 Jun, 17	-	-

- institutional shareholders have reduced their position in NDRA stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	1	-	670	148.15%	0.01%	15429.41%	1	-	-	-
31 Mar, 23	1	-	270	-	0.01%	11764.71%	-	-	-	-100.00%
31 Dec, 22	1	-93.33%	270	-99.99%	0.01%	0.00%	-	-100.00%	1	-66.67%
30 Sep, 22	15	-11.76%	3,546,597	-18.48%	112.28%	0.56%	4	-50.00%	3	50.00%
30 Jun, 22	17	-5.56%	4,350,698	10.22%	141.16%	0.42%	8	14.29%	2	-33.33%
31 Mar, 22	18	-5.26%	3,947,409	-10.76%	183.37%	0.39%	7	-12.50%	3	-
31 Dec, 21	19	5.56%	4,423,345	26.33%	216.18%	0.77%	8	60.00%	3	-40.00%
30 Sep, 21	18	-18.18%	3,501,341	-1.52%	167.08%	0.57%	5	-61.54%	5	400.00%
30 Jun, 21	22	4.76%	3,555,221	11.19%	170.61%	0.60%	13	-27.78%	1	-
31 Mar, 21	21	31.25%	3,197,296	21.51%	169.29%	0.23%	18	63.64%	1	-50.00%
31 Dec, 20	16	23.08%	2,631,249	180.98%	274.20%	4.46%	11	22.22%	2	100.00%
30 Sep, 20	13	-7.14%	936,463	27.80%	78.40%	0.79%	9	28.57%	1	-50.00%
30 Jun, 20	14	27.27%	732,752	-35.71%	99.45%	0.25%	7	40.00%	2	-
31 Mar, 20	11	-	1,139,805	24.89%	198.07%	0.79%	5	25.00%	2	-
31 Dec, 19	11	-8.33%	912,632	-11.43%	158.60%	0.21%	4	-	2	-33.33%
30 Sep, 19	12	20.00%	1,030,406	-5.52%	277.41%	0.32%	4	-	3	200.00%
30 Jun, 19	10	-28.57%	1,090,561	-4.19%	293.85%	0.31%	4	-60.00%	1	-
31 Mar, 19	14	7.69%	1,138,313	-8.15%	306.71%	0.10%	10	-	1	-
31 Dec, 18	13	44.44%	1,239,316	311.25%	550.21%	2.34%	10	42.86%	1	-
30 Sep, 18	9	125.00%	301,350	137.59%	153.44%	3.67%	7	250.00%	-	-
30 Jun, 18	4	-20.00%	126,836	73.15%	64.66%	4.64%	2	-50.00%	-	-
31 Mar, 18	5	150.00%	73,254	190.34%	37.35%	22.39%	4	100.00%	-	-
31 Dec, 17	2	100.00%	25,230	567.46%	12.92%	344.94%	2	100.00%	-	-
30 Sep, 17	1	-	3,780	80.00%	1.94%	65.14%	1	-	-	-
30 Jun, 17	1	-	2,100	-	1.72%	-	1	-	-	-

ENDRA Life Sciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 22, 2023	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	15,000	$1.65	$24.75K	34,139
May 03, 2023	DIGIANDOMENICO ANTHONY	director	-	P-Purchase	Buy	83,333	$1.20	$100.00K	102,434
May 03, 2023	DIGIANDOMENICO ANTHONY	director	-	P-Purchase	Buy	41,667	$1.40	$58.33K	41,667
Dec 13, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	1,500	$3.40	$5.10K	19,139
Nov 28, 2022	Tokman Alexander Y	director	-	P-Purchase	Buy	10,000	$0.17	$1.70K	162,857
Aug 24, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	20,000	$0.27	$5.40K	352,775
Aug 24, 2022	Tokman Alexander Y	director		P-Purchase	Buy	20,000	$0.26	$5.20K	152,857
May 31, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	25,000	$0.21	$5.25K	332,775

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 22, 2023	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	15,000	$1.65	$24.75K	34,139
May 03, 2023	DIGIANDOMENICO ANTHONY	director	-	P-Purchase	Buy	83,333	$1.20	$100.00K	102,434
May 03, 2023	DIGIANDOMENICO ANTHONY	director	-	P-Purchase	Buy	41,667	$1.40	$58.33K	41,667
Dec 13, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	1,500	$3.40	$5.10K	19,139
Nov 28, 2022	Tokman Alexander Y	director	-	P-Purchase	Buy	10,000	$0.17	$1.70K	162,857
Aug 24, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	20,000	$0.27	$5.40K	352,775
Aug 24, 2022	Tokman Alexander Y	director		P-Purchase	Buy	20,000	$0.26	$5.20K	152,857
May 31, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	25,000	$0.21	$5.25K	332,775

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 15, 2024	Jacroux Richard		-		Buy	-	-	-	-
Feb 23, 2024	Basenese Lou	director	-	A-Award	Buy	600	$1.59	$954.00	600
Feb 23, 2024	Harsh Michael	director	-	A-Award	Buy	600	$1.59	$954.00	600
Feb 23, 2024	DIGIANDOMENICO ANTHONY	director	-	A-Award	Buy	600	$1.59	$954.00	600
Feb 23, 2024	Tokman Alexander Y	director	-	A-Award	Buy	600	$1.59	$954.00	600
May 22, 2023	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	15,000	$1.65	$24.75K	34,139
May 03, 2023	DIGIANDOMENICO ANTHONY	director	-	P-Purchase	Buy	83,333	$1.20	$100.00K	102,434
May 03, 2023	DIGIANDOMENICO ANTHONY	director	-	P-Purchase	Buy	41,667	$1.40	$58.33K	41,667
Feb 01, 2023	Basenese Lou	director	-	A-Award	Buy	6,746	$4.02	$27.12K	6,746
Feb 01, 2023	Tokman Alexander Y	director	-	A-Award	Buy	9,621	$4.02	$38.68K	9,621
Feb 01, 2023	Harsh Michael	director	-	A-Award	Buy	9,634	$4.02	$38.73K	9,634
Feb 01, 2023	DIGIANDOMENICO ANTHONY	director	-	A-Award	Buy	9,621	$4.02	$38.68K	9,621
Feb 01, 2023	Pestrikova Irina	officer	Senior Director, Finance	A-Award	Buy	8,000	$4.02	$32.16K	8,000
Feb 01, 2023	Thornton Michael Milos	officer	Chief Technology Officer	A-Award	Buy	68,066	$4.02	$273.63K	68,066
Feb 01, 2023	Michelon Francois Roger	director, officer	Chief Executive Officer	A-Award	Buy	69,531	$4.02	$279.51K	69,531
Dec 13, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	1,500	$3.40	$5.10K	19,139
Nov 28, 2022	Tokman Alexander Y	director	-	P-Purchase	Buy	10,000	$0.17	$1.70K	162,857
Aug 24, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	20,000	$0.27	$5.40K	352,775
Aug 24, 2022	Tokman Alexander Y	director		P-Purchase	Buy	20,000	$0.26	$5.20K	152,857
May 31, 2022	Thornton Michael Milos	officer	Chief Technology Officer	P-Purchase	Buy	25,000	$0.21	$5.25K	332,775

The last insider buy of NDRA was made by Thornton Michael Milos on May 22 2023, buying 15,000 shares at $1.65 per share (worth $24.75K).

ENDRA Life Sciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	2	-	-
Q1 2023	7	-	-
Q4 2022	2	-	-
Q3 2022	2	-	-
Q2 2022	4	-	-
Q1 2022	12	-	-
Q3 2021	-	2	-
Q2 2021	9	3	300.00%
Q1 2021	6	8	75.00%
Q4 2020	1	4	25.00%
Q3 2020	2	2	100.00%
Q2 2020	25	8	312.50%
Q1 2020	6	-	-
Q4 2019	18	-	-
Q3 2019	3	-	-
Q2 2019	7	1	700.00%
Q1 2019	4	-	-
Q4 2018	7	7	100.00%
Q2 2018	8	-	-
Q1 2018	4	-	-

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by ENDRA Life Sciences's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	2	-	-
Q1 2023	-	-	-
Q4 2022	2	-	-
Q3 2022	2	-	-
Q2 2022	4	-	-
Q1 2022	-	-	-
Q3 2021	-	2	-
Q2 2021	-	1	-
Q1 2021	-	8	-
Q4 2020	-	4	-
Q3 2020	-	-	-
Q2 2020	8	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	3	-	-
Q2 2019	5	-	-
Q1 2019	-	-	-
Q4 2018	-	3	-
Q2 2018	-	-	-
Q1 2018	-	-	-

As of Q2 2023, Insider owners conducted 2 open market buy trades and 0 open market sell trades of ENDRA Life Sciences's stocks.

ENDRA Life Sciences Peer Ownership

Ticker	Company
GTH	Genetron Holdings Limited
HTGM	HTG Molecular Diagnostics, Inc.
LAB	Standard BioTools Inc.
SQL	SeqLL Inc.
SERA	Sera Prognostics, Inc.
BNR	Burning Rock Biotech Limited
DRIO	DarioHealth Corp.
BDSX	Biodesix, Inc.
INBS	Intelligent Bio Solutions Inc.
STIM	Neuronetics, Inc.

NDRA Ownership FAQ

Who Owns ENDRA Life Sciences?

ENDRA Life Sciences is owned by institutional shareholders (0.01%), insiders (0.32%), and public (99.67%). The largest institutional shareholder of ENDRA Life Sciences is WORTH ASSET MANAGEMENT, LLC (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of ENDRA Life Sciences?

ENDRA Life Sciences's major institutional shareholders are WORTH ASSET MANAGEMENT, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many ENDRA Life Sciences shareholders are there?

As of Jun 2023, there are 1 institutional shareholders of ENDRA Life Sciences.

What percentage of ENDRA Life Sciences is owned by WORTH ASSET MANAGEMENT, LLC?

WORTH ASSET MANAGEMENT, LLC owns 0 shares of ENDRA Life Sciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).